| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 18.11. | Agenus Taps Dr. José Iglesias as Chief Medical Affairs Officer | ||
| 18.11. | Halozyme Therapeutics Acquires Elektrofi for $750M | ||
| 18.11. | BioDuro Launches Peptide Business Unit | ||
| 18.11. | Thermo Fisher Scientific Opens Advanced Therapies Collaboration Center in Philadelphia | ||
| 18.11. | Debiopharm Launches IDEAL Japan Initiative | ||
| 18.11. | European Commission Approves Remsima IV Liquid Formulation | ||
| 17.11. | Solve Therapeutics Raises $120M in Latest Funding Round | ||
| 17.11. | Andelyn Biosciences Signs Licensing Agreement with Solid Biosciences | ||
| 17.11. | Merus, Halozyme Partner to Develop Subcutaneous Formulation of Petosemtamab | ||
| 17.11. | AdvanCell Appoints Philina Lee as CEO | ||
| 17.11. | Polpharma Biologics Launches Tyruko in the U.S. | ||
| 17.11. | Sonoma Biotherapeutics Names Stephen Dilly as CEO | ||
| 14.11. | Merck 3Q Results | ||
| 14.11. | Pfizer 3Q Results | ||
| 14.11. | Abbvie 3Q Results | ||
| 14.11. | TandemAI Secures $22M Series A Extension | ||
| 14.11. | Merck to Acquire Cidara Therapeutics | ||
| 13.11. | HHS Appoints Director of Center for Drug Evaluation and Research | ||
| 13.11. | Cytovance Biologics Celebrates 20 Years in Oklahoma City | ||
| 13.11. | Neurvati Neurosciences Appoints New Chief Commercial Officer | ||
| 13.11. | Domain Therapeutics Names Jean-Marie Cuillerot as Chief Medical Officer | ||
| 13.11. | JSR Life Sciences to Transfer Crown Bioscience to Adicon Holdings Ltd. | ||
| 12.11. | Mark Egerton Appointed Chairman of Panthera Biopartners | ||
| 12.11. | SCRI, BMS Expand Collaboration to Accelerate Patient Enrollment | ||
| 12.11. | Leukogene Therapeutics Receives Funding for Cancer Therapies |